Great-West Lifeco Inc.
TSX:GWO.TOInsurance - Life
+$0.74 today
- Market cap
- $84.18B
- Beta
- 0.70
- P/E (TTM)
- 18.1
- EPS (TTM)
- $4.95
- Dividend yield
- 2.86%
Volume 1.09M
Average 1.56M
GWO.TO Pre-Tax Margin
Income before tax as a percentage of revenue.
Great-West Lifeco Inc.TSX: GWO.TO
Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026
Pre-tax margin widens to 9.9%
Pre-tax margin was 9.9% in Q2 FY2026, up 0.8 pp from a year earlier. On a trailing-twelve-month basis it was 14.9%, up 3.8 pp year over year. Over 3 fiscal years it widened by 162.9 pp.
Context
- Pre-tax margin widened in 2 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
Pre-Tax Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 12.0%
- Year-over-year change
- -2.3pp
| Period | Period end | Pre-Tax Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 12.0% | -2.3pp |
| FY2024 | 2024-12-31 | 14.3% | +6.0pp |
| FY2023 | 2023-12-31 | 8.4% | +159.3pp |
| FY2022 | 2022-12-31 | -150.9% | -156.9pp |
| FY2021 | 2021-12-31 | 6.0% | — |
Pre-Tax Margin vs competitors
How GWO.TO compares with its peers on the latest reported figures
- GWO.TO's LTM Jun 2026 pre-tax margin of 14.9% is the 3rd highest of the 8 companies compared; the peer median is 11.2%.
- Its year-over-year change of +3.8 pp is the 2nd highest of 8, against a peer median of -1.2 pp.
- Over three fiscal years its change of +162.9 pp compares with a peer median of +9.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 61.6% | +12.7 pp | +9.7 pp | |
| LTM Sep 2026 | 29.7% | +0.3 pp | +3.2 pp | |
| LTM Jun 2026 | 14.9% | +3.8 pp | +162.9 pp | |
| LTM Jun 2026 | 14.5% | -1.2 pp | +26.7 pp | |
| LTM Jun 2026 | 11.2% | -0.2 pp | -93.3 pp | |
| LTM Jun 2026 | 10.9% | -3.6 pp | +21.7 pp | |
| LTM Jun 2026 | 6.2% | -1.7 pp | -3.3 pp | |
| LTM Mar 2026 | 5.6% | -7.4 pp | +145.4 pp | |
| Peer median (excluding GWO.TO) | 11.2% | -1.2 pp | +9.7 pp | |
Competitors are the stored peer set for GWO.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 64.45B | (2.69B) | 36.73B | 34.72B | 39.1B |
| Cost of Revenue | 51.52B | (13.75B) | 25.61B | 21.34B | 25.98B |
| Gross Profit | 12.93B | 11.06B | 11.12B | 13.39B | 13.13B |
| Gross Margin | 20.1% | -410.7% | 30.3% | 38.6% | 33.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 6.13B | 5.41B | 6.33B | 6.73B | 7.1B |
| Operating Expenses | 9.06B | 7B | 14.46B | 15.46B | 8.43B |
| Depreciation & Amortization | 523M | 516M | 505M | 556M | 579M |
| EBITDA | 4.72B | 4.96B | 3.98B | 5.93B | 5.64B |
| EBITDA Margin | 7.3% | -184.1% | 10.8% | 17.1% | 14.4% |
| Operating Income | 3.87B | 4.06B | (3.33B) | (2.07B) | 4.7B |
| Operating Margin | 6.0% | -150.9% | -9.1% | -6.0% | 12.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 349M | 393M | 426M | 402M | 379M |
| Other Income / Expenses | 0 | 0 | 6.4B | 7.05B | 0 |
| Income Before Tax | 3.87B | 4.06B | 3.07B | 4.98B | 4.7B |
| Pre-Tax Margin | 6.0% | -150.9% | 8.4% | 14.3% | 12.0% |
| Income Tax Expense | 304M | 394M | 53M | 737M | 534M |
| Net Income | 3.26B | 3.73B | 2.87B | 4.07B | 4.12B |
| Net Margin | 5.1% | -138.4% | 7.8% | 11.7% | 10.5% |
| EPS (Basic) | 3.37 | 3.86 | 2.94 | 4.23 | 4.29 |
| EPS (Diluted) | 3.36 | 3.86 | 2.93 | 4.21 | 4.26 |
| Weighted Avg Shares | 929.46M | 931.68M | 931.65M | 932.08M | 924.04M |
| Weighted Avg Shares (Diluted) | 930.96M | 932.28M | 933.53M | 935.12M | 928.77M |
Great-West Lifeco Inc.
TSX:GWO.TO
Intrinsic Alpha fair value
Locked
Current Price
$94.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.